Actinium Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.73-$1.72 |
Market Cap | $44.9M |
Shares Short | 631,234 |
Financials
See moreRevenue (12 Mos) | $35M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $35M |
Diluted EPS | $0.36 |
News
See moreYahoo Finance • 13 days ago
Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Cancer at ESMO 2026
Yahoo Finance • 20 days ago
Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development
Yahoo Finance • last year
Sector Update: Health Care Stocks Advance Monday Afternoon
Yahoo Finance • last year
Actinium Highlights ATNM 400 Progress at SNMMI Conference
About
CEO | Mr. Sandesh C. Seth M.B.A., M.S. |
CFO | Dr. Matthew T. David M.D. |
Address | 100 Park Avenue, New York, NY, United States, 10017 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |